Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Nifedipine API Market Report 2016

  • QYR829868
  • 111 Pages
  • December 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Nifedipine API

Revenue, means the sales value of Nifedipine API

This report studies sales (consumption) of Nifedipine API in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Bayer AG

ZACH SYSTEM SPA

Teva Group

Dipharma Francis S.r.l.

Delmar Chemicals Inc.

Moehs Iberica S.L.

Sumika Fine Chemicals Co., Ltd.

CIPLA Ltd

Dipharma Francis S.r.l

Tecoland Corp

Zhong’an Pharmaceutical

Siyao Pharmaceuticals

Xiyue Pharmaceutical

Qingyang Pharmaceutical

Luyin Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

98% Nifedipine API

99% Nifedipine API

99.9% Nifedipine API

Split by applications, this report focuses on sales, market share and growth rate of Nifedipine API in each application, can be divided into

Controlled Release Tablets

Extended Action Tablets

Modified Release Capsule

Table of Contents

United States Nifedipine API Market Report 2016

1 Nifedipine API Overview

1.1 Product Overview and Scope of Nifedipine API

1.2 Classification of Nifedipine API

1.2.1 98% Nifedipine API

1.2.2 99% Nifedipine API

1.2.3 99.9% Nifedipine API

1.3 Application of Nifedipine API

1.3.1 Controlled Release Tablets

1.3.2 Extended Action Tablets

1.3.3 Modified Release Capsule

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nifedipine API (2011-2021)

1.4.1 United States Nifedipine API Sales and Growth Rate (2011-2021)

1.4.2 United States Nifedipine API Revenue and Growth Rate (2011-2021)

2 United States Nifedipine API Competition by Manufacturers

2.1 United States Nifedipine API Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Nifedipine API Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Nifedipine API Average Price by Manufactures (2015 and 2016)

2.4 Nifedipine API Market Competitive Situation and Trends

2.4.1 Nifedipine API Market Concentration Rate

2.4.2 Nifedipine API Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Nifedipine API Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Nifedipine API Sales and Market Share by Type (2011-2016)

3.2 United States Nifedipine API Revenue and Market Share by Type (2011-2016)

3.3 United States Nifedipine API Price by Type (2011-2016)

3.4 United States Nifedipine API Sales Growth Rate by Type (2011-2016)

4 United States Nifedipine API Sales (Volume) by Application (2011-2016)

4.1 United States Nifedipine API Sales and Market Share by Application (2011-2016)

4.2 United States Nifedipine API Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Nifedipine API Manufacturers Profiles/Analysis

5.1 Bayer AG

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Nifedipine API Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Bayer AG Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 ZACH SYSTEM SPA

5.2.2 Nifedipine API Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 ZACH SYSTEM SPA Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Teva Group

5.3.2 Nifedipine API Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Teva Group Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Dipharma Francis S.r.l.

5.4.2 Nifedipine API Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Dipharma Francis S.r.l. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Delmar Chemicals Inc.

5.5.2 Nifedipine API Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Delmar Chemicals Inc. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Moehs Iberica S.L.

5.6.2 Nifedipine API Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Moehs Iberica S.L. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Sumika Fine Chemicals Co., Ltd.

5.7.2 Nifedipine API Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Sumika Fine Chemicals Co., Ltd. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 CIPLA Ltd

5.8.2 Nifedipine API Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 CIPLA Ltd Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Dipharma Francis S.r.l

5.9.2 Nifedipine API Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Dipharma Francis S.r.l Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Tecoland Corp

5.10.2 Nifedipine API Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Tecoland Corp Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Zhong’an Pharmaceutical

5.12 Siyao Pharmaceuticals

5.13 Xiyue Pharmaceutical

5.14 Qingyang Pharmaceutical

5.15 Luyin Pharmaceutical

6 Nifedipine API Manufacturing Cost Analysis

6.1 Nifedipine API Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Nifedipine API

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Nifedipine API Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Nifedipine API Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Nifedipine API Market Forecast (2016-2021)

10.1 United States Nifedipine API Sales, Revenue Forecast (2016-2021)

10.2 United States Nifedipine API Sales Forecast by Type (2016-2021)

10.3 United States Nifedipine API Sales Forecast by Application (2016-2021)

10.4 Nifedipine API Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Nifedipine API

Table Classification of Nifedipine API

Figure United States Sales Market Share of Nifedipine API by Type in 2015

Figure 98% Nifedipine API Picture

Figure 99% Nifedipine API Picture

Figure 99.9% Nifedipine API Picture

Table Application of Nifedipine API

Figure United States Sales Market Share of Nifedipine API by Application in 2015

Figure Controlled Release Tablets Examples

Figure Extended Action Tablets Examples

Figure Modified Release Capsule Examples

Figure United States Nifedipine API Sales and Growth Rate (2011-2021)

Figure United States Nifedipine API Revenue and Growth Rate (2011-2021)

Table United States Nifedipine API Sales of Key Manufacturers (2015 and 2016)

Table United States Nifedipine API Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Nifedipine API Sales Share by Manufacturers

Figure 2016 Nifedipine API Sales Share by Manufacturers

Table United States Nifedipine API Revenue by Manufacturers (2015 and 2016)

Table United States Nifedipine API Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Nifedipine API Revenue Share by Manufacturers

Table 2016 United States Nifedipine API Revenue Share by Manufacturers

Table United States Market Nifedipine API Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Nifedipine API Average Price of Key Manufacturers in 2015

Figure Nifedipine API Market Share of Top 3 Manufacturers

Figure Nifedipine API Market Share of Top 5 Manufacturers

Table United States Nifedipine API Sales by Type (2011-2016)

Table United States Nifedipine API Sales Share by Type (2011-2016)

Figure United States Nifedipine API Sales Market Share by Type in 2015

Table United States Nifedipine API Revenue and Market Share by Type (2011-2016)

Table United States Nifedipine API Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Nifedipine API by Type (2011-2016)

Table United States Nifedipine API Price by Type (2011-2016)

Figure United States Nifedipine API Sales Growth Rate by Type (2011-2016)

Table United States Nifedipine API Sales by Application (2011-2016)

Table United States Nifedipine API Sales Market Share by Application (2011-2016)

Figure United States Nifedipine API Sales Market Share by Application in 2015

Table United States Nifedipine API Sales Growth Rate by Application (2011-2016)

Figure United States Nifedipine API Sales Growth Rate by Application (2011-2016)

Table Bayer AG Basic Information List

Table Bayer AG Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer AG Nifedipine API Sales Market Share (2011-2016)

Table ZACH SYSTEM SPA Basic Information List

Table ZACH SYSTEM SPA Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table ZACH SYSTEM SPA Nifedipine API Sales Market Share (2011-2016)

Table Teva Group Basic Information List

Table Teva Group Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Group Nifedipine API Sales Market Share (2011-2016)

Table Dipharma Francis S.r.l. Basic Information List

Table Dipharma Francis S.r.l. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dipharma Francis S.r.l. Nifedipine API Sales Market Share (2011-2016)

Table Delmar Chemicals Inc. Basic Information List

Table Delmar Chemicals Inc. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Delmar Chemicals Inc. Nifedipine API Sales Market Share (2011-2016)

Table Moehs Iberica S.L. Basic Information List

Table Moehs Iberica S.L. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Moehs Iberica S.L. Nifedipine API Sales Market Share (2011-2016)

Table Sumika Fine Chemicals Co., Ltd. Basic Information List

Table Sumika Fine Chemicals Co., Ltd. Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sumika Fine Chemicals Co., Ltd. Nifedipine API Sales Market Share (2011-2016)

Table CIPLA Ltd Basic Information List

Table CIPLA Ltd Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table CIPLA Ltd Nifedipine API Sales Market Share (2011-2016)

Table Dipharma Francis S.r.l Basic Information List

Table Dipharma Francis S.r.l Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dipharma Francis S.r.l Nifedipine API Sales Market Share (2011-2016)

Table Tecoland Corp Basic Information List

Table Tecoland Corp Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Tecoland Corp Nifedipine API Sales Market Share (2011-2016)

Table Zhong’an Pharmaceutical Basic Information List

Table Zhong’an Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zhong’an Pharmaceutical Nifedipine API Sales Market Share (2011-2016)

Table Siyao Pharmaceuticals Basic Information List

Table Siyao Pharmaceuticals Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Siyao Pharmaceuticals Nifedipine API Sales Market Share (2011-2016)

Table Xiyue Pharmaceutical Basic Information List

Table Xiyue Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Xiyue Pharmaceutical Nifedipine API Sales Market Share (2011-2016)

Table Qingyang Pharmaceutical Basic Information List

Table Qingyang Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Qingyang Pharmaceutical Nifedipine API Sales Market Share (2011-2016)

Table Luyin Pharmaceutical Basic Information List

Table Luyin Pharmaceutical Nifedipine API Sales, Revenue, Price and Gross Margin (2011-2016)

Table Luyin Pharmaceutical Nifedipine API Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Nifedipine API

Figure Manufacturing Process Analysis of Nifedipine API

Figure Nifedipine API Industrial Chain Analysis

Table Raw Materials Sources of Nifedipine API Major Manufacturers in 2015

Table Major Buyers of Nifedipine API

Table Distributors/Traders List

Figure United States Nifedipine API Production and Growth Rate Forecast (2016-2021)

Figure United States Nifedipine API Revenue and Growth Rate Forecast (2016-2021)

Table United States Nifedipine API Production Forecast by Type (2016-2021)

Table United States Nifedipine API Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370